Skip to content
DraconiticResearch
Search Sources API
226,742 studies31 sourcesUpdated 40 min ago
Peer-reviewedCC BY-NC-NDLa Tunisie medicale

Moyamoya Syndrome as a Severe Cerebrovascular Complication of Mucopolysaccharidosis Type I: Clinical Presentation and Underlying Mechanisms Le syndrome de Moyamoya, complication cérébrovasculaire majeure de la mucopolysaccharidose de type I: Aspects cliniques et mécanismes physiopathologiques

5 affiliations
  1. 1Internal medicine department, Bab El Oued University Hospital center, Bab El Oued city, Faculty of Medicine, University of health sciences, Algiers, Algeria
  2. 2Radiology department, Bab El Oued University Hospital center, Bab El Oued city, Faculty of Medicine, University of health sciences, Algiers, Algeria
  3. 3Nephrology Department, Mustapha Bacha University Hospital Center, University of health sciences, Algiers, Algeria
  4. 4Rheumatology department, Benaknoun University Hospital center, Faculté of Medicine, University of health sciences, Algiers, Algeria
  5. 5Department of Hepato-gastro-enterology, Bab El Oued University Hospital center, Bab El Oued city, Algiers, Algeria

Related

  1. Early Recognition of Patients with Neuronopathic Forms of Mucopolysaccharidosis Type II in Clinical Practice
    Natalia V. Buchinskaia, Ekaterina Yu. Zakharova, Anastasia O. Vechkasova +6
    Medical sciences (Basel, Switzerland)Peer-reviewedCC BYFull textGeneral medicineEurope PMC
  2. Orthopaedic Manifestations of Mucopolysaccharidosis.
    Chris Tremonti, Elle Bui, Klane K White +1
    Journal of the Pediatric Orthopaedic Society of North AmericaPeer-reviewedCC BY-NC-NDFull textHuman geneticsEurope PMCPMC
  3. Induction of Oral Immune Tolerance Enables Sequential AAV9/AAV8 Gene Therapy in Mucopolysaccharidosis IVA
    Sampurna Saikia, Krishna Sai Musini, Shaukat Khan +1
    International Journal of Molecular SciencesPeer-reviewedCC BY 4.0PhysiologyCrossref
  4. Synthesis of the Endogenous Non-Reducing End Heparan Sulfate Disaccharides for Newborn Screening and Diagnosis of Mucopolysaccharidosis types I and II
    Gurpreet Singh, Sachin Popat Gholap, Sanghyun Lim +2
    Carbohydrate researchPeer-reviewedCC BY-NC-NDFull textPhysiologyPMC
  5. Structural damage of the cervical spinal cord within and beyond the maximal compression area in mucopolysaccharidosis types I and VI
    Igor Nestrašil, Christophe Lenglet, Ivan Krasovec +8
    medRxivPreprintCC BY-NCFull textMedical imaging & radiologymedRxivPMC
BibTeX
@article{daghorabbaci2026moyamoya,
  title = {{Moyamoya Syndrome as a Severe Cerebrovascular Complication of Mucopolysaccharidosis Type I: Clinical Presentation and Underlying Mechanisms Le syndrome de Moyamoya, complication cérébrovasculaire majeure de la mucopolysaccharidose de type I: Aspects cliniques et mécanismes physiopathologiques}},
  author = {Karima Daghor-Abbaci and Radhia Ait Chalal and Hind Arzour and Assia Haddouche and Houria Saoula and Nazim Laraba},
  journal = {La Tunisie medicale},
  year = {2026},
  month = jul,
  doi = {10.62438/tunismed.v104i07.6678},
  url = {https://europepmc.org/article/PMC/PMC13751068},
  note = {CC BY-NC-ND},
}
RIS
TY  - JOUR
TI  - Moyamoya Syndrome as a Severe Cerebrovascular Complication of Mucopolysaccharidosis Type I: Clinical Presentation and Underlying Mechanisms Le syndrome de Moyamoya, complication cérébrovasculaire majeure de la mucopolysaccharidose de type I: Aspects cliniques et mécanismes physiopathologiques
AU  - Karima Daghor-Abbaci
AU  - Radhia Ait Chalal
AU  - Hind Arzour
AU  - Assia Haddouche
AU  - Houria Saoula
AU  - Nazim Laraba
PY  - 2026
DA  - 2026/07/01
JO  - La Tunisie medicale
DO  - 10.62438/tunismed.v104i07.6678
UR  - https://europepmc.org/article/PMC/PMC13751068
SN  - 0041-4131
SN  - 2724-7031
ER  -